Elon Musk‘s Neuralink has registered a study for its brain implant with the U.S. government. The company is looking to enroll three patients for the trial, which is expected to span several years. What Happened: Neuralink, the brain-chip company founded by Musk, is seeking to evaluate its device in a clinical trial. The study, which is anticipated to conclude in 2031, aims to test the implant’s potential to enable paralyzed patients to operate digital devices using their thoughts, Reuters reported. The trial will include patients aged 22 to 75 with conditions such as quadriplegia. The study’s …
